Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?

Am J Gastroenterol. 2016 Aug;111(8):1208-9. doi: 10.1038/ajg.2016.214.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / drug therapy*
  • End Stage Liver Disease / complications
  • Female
  • Hepatitis C, Chronic / complications
  • Humans
  • Liver Cirrhosis / complications
  • Liver Neoplasms / complications
  • Liver Neoplasms / drug therapy*
  • Nivolumab
  • Remission Induction

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Nivolumab